Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / ARWR - Arrowhead Pharmaceuticals Inc. (ARWR) CEO Dr. Christopher Anzalone on Q1 2022 Results - Earnings Call Transcript

ARWR - Arrowhead Pharmaceuticals Inc. (ARWR) CEO Dr. Christopher Anzalone on Q1 2022 Results - Earnings Call Transcript

Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals, Inc. (ARWR) Q1 2022 Results Conference Call February 02, 2022 04:30 PM ET Company Participants Vince Anzalone - VP, IR Dr. Christopher Anzalone - President and CEO Dr. Javier San Martin - Chief Medical Officer Ken Myszkowski - CFO Dr. James Hamilton - SVP, Discovery and Translational Medicine James Hassard - Chief Commercial Officer Conference Call Participants Madhu Kumar - Goldman Sachs Maury Raycroft - Jefferies Ted Tenthoff - Piper Sandler Mayank Mamtani - B. Riley Securities Patrick Trucchio - H.C. Wainwright Luca Issi - RBC Capital Alethia Young - Cantor Fitzgerald Joel Beatty - Baird Mani Foroohar - SVB Leerink Keay Nakae - Chardan Presentation Operator Ladies and gentlemen, welcome to the Arrowhead Pharmaceuticals Conference Call. Throughout today's recorded presentation, all participants will be in a listen-only mode. After the presentation, there will be an opportunity to ask questions. I will now hand the conference call over

For further details see:

Arrowhead Pharmaceuticals, Inc. (ARWR) CEO Dr. Christopher Anzalone on Q1 2022 Results - Earnings Call Transcript
Stock Information
Company Name: Arrowhead Pharmaceuticals Inc.
Stock Symbol: ARWR
Market: NASDAQ
Website: arrowheadpharma.com
Menu
ARWR ARWR Quote ARWR Short ARWR News ARWR Articles ARWR Message Board
Get ARWR Alerts

News, Short Squeeze, Breakout and More Instantly...